Bank of New York Mellon Corp purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,551,492 shares of the semiconductor company's stock, valued at approximately $692,074,000. Bank of New York Mellon Corp owned 0.81% of Synopsys as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also modified their holdings of SNPS. China Universal Asset Management Co. Ltd. lifted its holdings in Synopsys by 31.8% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company's stock valued at $6,957,000 after acquiring an additional 3,575 shares during the last quarter. Norges Bank acquired a new position in shares of Synopsys in the 4th quarter worth approximately $730,197,000. SBI Okasan Asset Management Co.Ltd. bought a new stake in shares of Synopsys in the 4th quarter worth approximately $1,699,000. Atreides Management LP acquired a new stake in Synopsys during the first quarter valued at approximately $54,288,000. Finally, Mizuho Markets Americas LLC acquired a new stake in Synopsys during the first quarter valued at approximately $20,182,000. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Down 0.8%
NASDAQ:SNPS opened at $397.92 on Friday. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $615.79. The firm has a market capitalization of $76.19 billion, a price-to-earnings ratio of 92.11, a PEG ratio of 2.36 and a beta of 1.23. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The business's fifty day moving average price is $420.85 and its 200 day moving average price is $440.51.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business's revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several research firms have issued reports on SNPS. Rosenblatt Securities lifted their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a "buy" rating in a research report on Tuesday, May 26th. Benchmark reiterated a "buy" rating on shares of Synopsys in a research report on Wednesday. Robert W. Baird set a $558.00 price objective on Synopsys in a research note on Thursday, May 28th. BNP Paribas Exane lifted their target price on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a report on Thursday, May 28th. Finally, Zacks Research raised Synopsys from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $563.59.
Get Our Latest Analysis on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business's stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company's stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.